Silver Book Fact

From approval in 2011 through 2015 >54,000 TAVRs were performed in 418 centers in 48 states

Fact image

Grover F, Vemalapalli S, Carroll J, et al. 2016 Annual Report of The Society for Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry. Ann Thorac Surg. 2017; 103(3). http://www.sciencedirect.com/science/article/pii/S0003497516317659

Reference

Title
2016 Annual Report of The Society for Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry
Publication
Ann Thorac Surg
Publication Date
2017
Authors
Grover F, Vemalapalli S, Carroll J, et al
Volume & Issue
Volume 103, Issue 3
Pages
102-35
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • TAVR Procedures 2011 – 2015
    From approval in 2011 through 2015, >54,000 transcatheter aortic valve replacements (TAVRs) were performed in 418 centers in 48 states.  
  • Cost-effectiveness of SAVR
    The cost-effectiveness ratio for surgical aortic valve replacement (SAVR), compared to no surgery, was estimated at $13,528 per quality-adjusted life year (QALY) (~$17,225 in 2017 dollars).  
  • Life expectancy and quality of life gains from AVR
    A study of 4,617 patients who underwent aortic valve replacement (AVR) over a period of 20 years found significant gains in life expectancy and quality of life — 43,166 net life-years…  
  • Disease specific status and generic health status improvements from TAVR and SAVR
    Transcatheter aortic valve replacement (TAVR) and surgical aortic valve replacement (SAVR) in intermediate risk symptomatic aortic stenosis (SAS) patients were associated with significant improvements in disease specific status (16 to…  
  • Improvements in QoL from TAVR in SAS patients
    Symptomatic aortic stenosis (SAS) patients who underwent transcatheter aortic valve replacement (TAVR) experienced quality of life (QoL) improvements from 5.3 at baseline (10 point scale with 10=best imaginable health state)…